Isofluranum [Inn-Latin] en es it fr

Isofluranum [Inn-Latin] Brand names, Isofluranum [Inn-Latin] Analogs

Isofluranum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Isofluranum [Inn-Latin] Chemical_Formula


Isofluranum [Inn-Latin] RX_link

Isofluranum [Inn-Latin] fda sheet

Isofluranum [Inn-Latin] msds (material safety sheet)

Isofluranum_[Inn-Latin] MSDS

Isofluranum [Inn-Latin] Synthesis Reference

No information avaliable

Isofluranum [Inn-Latin] Molecular Weight

184.492 g/mol

Isofluranum [Inn-Latin] Melting Point

49 oC (BP)

Isofluranum [Inn-Latin] H2O Solubility


Isofluranum [Inn-Latin] State


Isofluranum [Inn-Latin] LogP


Isofluranum [Inn-Latin] Dosage Forms


Isofluranum [Inn-Latin] Indication

For induction and maintenance of general anesthesia.

Isofluranum [Inn-Latin] Pharmacology

Isoflurane is a general inhalation anesthetic used for induction and maintenance of general anesthesia. It induces muscle relaxation and reduces pains sensitivity by altering tissue excitability. It does so by decreasing the extent of gap junction mediated cell-cell coupling and altering the activity of the channels that underlie the action potential.

Isofluranum [Inn-Latin] Absorption

No information avaliable

Isofluranum [Inn-Latin] side effects and Toxicity

LC50=15300 ppm/3 hrs (inhalation by rat)

Isofluranum [Inn-Latin] Patient Information

Isoflurane, as well as other general anesthetics, may cause a slight decrease in intellectual function for 2 or 3 days following anesthesia. As with other anesthetics, small changes in moods and symptoms may persist for up to 6 days after administration.

Isofluranum [Inn-Latin] Organisms Affected

Humans and other mammals